NEUROTROPHIC KERATITIS
Clinical trials for NEUROTROPHIC KERATITIS explained in plain language.
Never miss a new study
Get alerted when new NEUROTROPHIC KERATITIS trials appear
Sign up with your email to follow new studies for NEUROTROPHIC KERATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye drops aim to heal corneas in rare nerve damage condition
Disease control Recruiting nowThis study tests an experimental eye drop called STSP-0902 for people with neurotrophic keratitis, a rare eye disease where the cornea loses feeling and can develop sores or ulcers. About 48 adults with moderate to severe disease will receive either the drug or a placebo for 8 we…
Matched conditions: NEUROTROPHIC KERATITIS
Phase: PHASE2 • Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Gene therapy eye drops aim to heal corneas in rare disease
Disease control Recruiting nowThis study tests an experimental eye drop called KB801 for people with stage 2 or 3 neurotrophic keratitis, a condition where the cornea loses feeling and develops persistent sores. The drop delivers a gene that produces nerve growth factor to help heal the cornea. About 60 adult…
Matched conditions: NEUROTROPHIC KERATITIS
Phase: PHASE1, PHASE2 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New eye drop hopes to restore feeling to numb corneas
Symptom relief Recruiting nowThis study tests an eye drop called Lacripep for people with neurotrophic keratitis, a rare eye disease where the cornea loses feeling and doesn't heal properly. About 54 adults with early-stage disease will receive either the active drop or a placebo for 8 weeks. The goal is to …
Matched conditions: NEUROTROPHIC KERATITIS
Phase: PHASE2 • Sponsor: TearSolutions, Inc. • Aim: Symptom relief
Last updated May 22, 2026 14:04 UTC